Literature DB >> 30137623

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary.

Christopher R Holroyd1, Rakhi Seth1, Marwan Bukhari2, Anshuman Malaviya3, Claire Holmes1, Elizabeth Curtis4, Christopher Chan1, Mohammed A Yusuf3, Anna Litwic4,5, Susan Smolen3, Joanne Topliffe3, Sarah Bennett1, Jennifer Humphreys6, Muriel Green7, Jo Ledingham8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30137623     DOI： 10.1093/rheumatology/key207

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Impact of Rheumatoid Arthritis and Its Management on Falls, Fracture and Bone Mineral Density in UK Biobank.

Authors:  Michael A Clynes; Karen Jameson; Daniel Prieto-Alhambra; Nicholas C Harvey; Cyrus Cooper; Elaine M Dennison
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-26       Impact factor: 5.555

Review 2.  The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus.

Authors:  Eun-Jung Park; Hyungjin Kim; Seung Min Jung; Yoon-Kyoung Sung; Han Joo Baek; Jisoo Lee
Journal:  Korean J Intern Med       Date:  2020-01-02       Impact factor: 2.884

3.  Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries.

Authors:  Lianne Kearsley-Fleet; Jens Klotsche; Joeri W van Straalen; Wendy Costello; Gianfranco D'Angelo; Gabriella Giancane; Gerd Horneff; Ariane Klein; Matilda Láday; Mark Lunt; Sytze de Roock; Nicolino Ruperto; Casper Schoemaker; Gordana Vijatov-Djuric; Jelena Vojinovic; Olga Vougiouka; Nico M Wulffraat; Kimme L Hyrich; Kirsten Minden; Joost F Swart
Journal:  Rheumatology (Oxford)       Date:  2022-05-30       Impact factor: 7.046
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.